575 related articles for article (PubMed ID: 16918063)
1. Successful treatment of visceral leishmaniasis with liposomal amphotericin B.
Lagler H; Matt U; Sillaber C; Winkler S; Graninger W
Acta Biomed; 2006; 77 Suppl 2():22-5. PubMed ID: 16918063
[TBL] [Abstract][Full Text] [Related]
2. [Fever, pancytopenia, and splenomegaly 8 months after a trip to Majorca Island (Spain)].
Lübbert C; Opitz BM; Harms-Zwingenberger G; Nietsch HH
Med Klin (Munich); 2008 Jan; 103(1):29-35. PubMed ID: 18219460
[TBL] [Abstract][Full Text] [Related]
3. [Pancytopenia, fever, and splenomegaly in a 2-year-old boy].
Schmid MB; Leichsenring M; Keller C; Hegasy G
Dtsch Med Wochenschr; 2009 Jun; 134(24):1274-7. PubMed ID: 19499498
[TBL] [Abstract][Full Text] [Related]
4. Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B.
Tavil B; Seçmeer G; Ozen H; Cengiz AB; Unal S; Gürgey A
Turk J Pediatr; 2008; 50(1):67-9. PubMed ID: 18365595
[TBL] [Abstract][Full Text] [Related]
5. [Case report: the efficacy of amphotericin B in visceral leishmaniasis].
Güleç SG; Kizilyer Y; Karaman S; Erdem E; Urganci N
Turkiye Parazitol Derg; 2010; 34(2):73-5. PubMed ID: 20597048
[TBL] [Abstract][Full Text] [Related]
6. Visceral leishmaniasis and Coombs' positive hemolytic anemia: a rare association in an infant treated with liposomal amphotericin B.
Dilber E; Erduran E; Işik Y
Turk J Pediatr; 2002; 44(4):354-6. PubMed ID: 12458816
[TBL] [Abstract][Full Text] [Related]
7. Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B.
Beltrame A; Arzese A; Camporese A; Rorato G; Crapis M; Tarabini-Castellani G; Boscutti G; Pizzolitto S; Calianno G; Matteelli A; Di Muccio T; Gramiccia M; Viale P
J Travel Med; 2008; 15(5):358-60. PubMed ID: 19006511
[TBL] [Abstract][Full Text] [Related]
8. The hunt for an elusive source of pyrexia in a foreign worker.
Lew JW; Koh CK; Selvan VS; Shen E
Singapore Med J; 2007 Apr; 48(4):e111-3. PubMed ID: 17384865
[TBL] [Abstract][Full Text] [Related]
9. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
Manfredi R; Marinacci G; Calza L; Passarini B
Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
[No Abstract] [Full Text] [Related]
10. Monoclonal gammopathy in human leishmaniasis.
Randi ML; Ruzzon E; Tezza F; Tezza F; Pacquola E; Fabris F
Neth J Med; 2006 Feb; 64(2):50-1. PubMed ID: 16517989
[TBL] [Abstract][Full Text] [Related]
11. [Pancytopenia, hepatosplenomegaly and dry cough after breast cancer].
Seilmaier M; Hecht A; Guggemos W; Adorf D; Gehbauer G
Dtsch Med Wochenschr; 2009 Jun; 134(24):1269-73. PubMed ID: 19499497
[TBL] [Abstract][Full Text] [Related]
12. [First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].
Minodier P; Robert S; Noël G; Blanc P; Retornaz K; Garnier JM
Arch Pediatr; 2005 Jul; 12(7):1102-8. PubMed ID: 15964525
[TBL] [Abstract][Full Text] [Related]
13. Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome).
Boletis JN; Pefanis A; Stathakis C; Helioti H; Kostakis A; Giamarellou H
Clin Infect Dis; 1999 Jun; 28(6):1308-9. PubMed ID: 10451172
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
[TBL] [Abstract][Full Text] [Related]
15. A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience.
Cascio A; di Martino L; Occorsio P; Giacchino R; Catania S; Gigliotti AR; Aiassa C; Iaria C; Giordano S; Colomba C; Polara VF; Titone L; Gradoni L; Gramiccia M; Antinori S
J Antimicrob Chemother; 2004 Jul; 54(1):217-20. PubMed ID: 15150166
[TBL] [Abstract][Full Text] [Related]
16. U.S Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.
Berman JD
Clin Infect Dis; 1999 Jan; 28(1):49-51. PubMed ID: 10391695
[No Abstract] [Full Text] [Related]
17. Liposomal amphotericin B for the treatment of visceral leishmaniasis.
Bern C; Adler-Moore J; Berenguer J; Boelaert M; den Boer M; Davidson RN; Figueras C; Gradoni L; Kafetzis DA; Ritmeijer K; Rosenthal E; Royce C; Russo R; Sundar S; Alvar J
Clin Infect Dis; 2006 Oct; 43(7):917-24. PubMed ID: 16941377
[TBL] [Abstract][Full Text] [Related]
18. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.
Meyerhoff A
Clin Infect Dis; 1999 Jan; 28(1):42-8; discussion 49-51. PubMed ID: 10028069
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
[TBL] [Abstract][Full Text] [Related]
20. Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.
Venizelos I; Tatsiou Z; Papathomas TG; Orazi A
Int J Infect Dis; 2009 Jul; 13(4):e169-72. PubMed ID: 19026580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
